Merck’s $1.85 Billion Acquisition of Pandion Therapeutics

Troutman Pepper Hamilton Sanders LLP advised Pandion Therapeutics, Inc. on the deal.Pandion Therapeutics, Inc., a clinical-stage biotechnology company developing novel therapeutics for those living with autoimmune…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here